Smaller Companies: Gene genius from Amersham

Scientists across the world are united in a major effort to map out the complete sequence of human genes: the Human Genome Project. The numbers are awesome - 100 million genes, 3 billion pairs of DNA. Completion of this vast task is now expected before the end of the decade with major implications for medical science.

Amersham International, the Tories' first privatisation, has the skills to reap real benefits from the project. The last few years have been a roller coaster ride for group. Spun off originally from the Atomic Energy Authority, it prospered after the 1982 flotation, boosted by its core life sciences division - which supplies radioactive materials for public and private sector laboratories. Later in the decade, however, the boffins lost their way with an expensive effort to develop blood testing kits.

Bill Castell was then drafted in from Wellcome, as group chief executive, to inject some commercial vigour. After disappointing profits growth, the shares have marked time since 1993. The last two sets of half time figures, however, have come in ahead, fuelling renewed hope for the shares.

Amersham's core expertise still revolves around radioactivity. But the star now, which barely existed in the early 1980s, is branded healthcare products. In the latest six months to 30 September, divisional profits grew 139 per cent to pounds 14.1m - half of total operating profits of pounds 28.7m. A com- bination of acquisitions and new licence approvals have made Amersham the world leader in nuclear medicine, with roughly a third of the market.

One of its products, Metastron, is used for the relief of pain caused by secondary bone cancers. But faster growth is being achieved by diagnostic products, in particular Myoview, which enables doctors to monitor heart disease without surgery. In two years Myoview has taken a large chunk of the European and Japanese markets and is showing signs of doing equally well in the $120m a year US market after approval last April.

A notable coup has been a deal with Sumitomo to merge the Japanese giant's nuclear medicine business with Amersham's much smaller operation there. For pounds 106m the group has a 50 per cent stake in Nihon Medi-Physics (NMP), increasing its share of the Japanese nuclear medicine market tenfold to 67 per cent.

Ultimately the hope is that NMP will use Amersham's global network to gain worldwide distribution for its products.

Looking vigorous, too, is life sciences. Amersham has been improving the non-radioactive side of the business, based on luminescent products, and targeting drugs companies rather than public sector bodies.

At the same time it has been increasing its capabilities in genetic studies. This September, Amersham and bigger rivals Roche and Perkins Elmer swept aside complex arguments about patent protection and gave each other free access to all markets with royalties payable when one of the three is selling the other's product. The effect is to quadruple, to $240m, the market which Amersham can address with its new gene-sequencing products.

Last but not least are promising drugs in the pipeline, including agents to diagnose Parkinson's disease, Alzheimer's and cancer. One analyst is looking for profits to grow from pounds 50.8m to pounds 66.5m this year, followed by pounds 78.5m. With the shares now priced at 1,091p, that would leave the rating in the mid teens. Good value for a company with developments poised to capture the imagination.

Sport
Club legend Paul Scholes is scared United could disappear into 'the wilderness'
football
News
A model of a Neanderthal man on display at the National Museum of Prehistory in Dordogne, France
science
News
Dawkins: 'There’s a very interesting reason why a prince could not turn into a frog – it's statistically too improbable'
newsThat's Richard Dawkins on babies with Down Syndrome
Arts and Entertainment
Eye of the beholder? 'Concrete lasagne' Preston bus station
architectureWhich monstrosities should be nominated for the Dead Prize?
PROMOTED VIDEO
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Travel
Dinosaurs Unleashed at the Eden Project
travel
Arts and Entertainment
music
Sport
football
Life and Style
This month marks the 20th anniversary of the first online sale
techDespite a host of other online auction sites and fierce competition from Amazon, eBay is still the most popular e-commerce site in the UK
News
i100
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Quantitative Analyst (Financial Services, Graduate, SQL, VBA)

£45000 per annum: Harrington Starr: Quantitative Analyst (Financial Services, ...

Application Support Engineer (C++, .NET, VB, Perl, Bash, SQL)

Negotiable: Harrington Starr: Application Support Engineer (C++, .NET, VB, Per...

AIFMD Business Analyst / Consultant - Investment Management

£450 - £600 per day: Harrington Starr: AIFMD Business Analyst / Consultant - I...

Business Analyst Solvency II SME (Pillar 1, 2 & 3) Insurance

£450 - £600 per day: Harrington Starr: Business Analyst Solvency II SME (Pilla...

Day In a Page

Middle East crisis: We know all too much about the cruelty of Isis – but all too little about who they are

We know all too much about the cruelty of Isis – but all too little about who they are

Now Obama has seen the next US reporter to be threatened with beheading, will he blink, asks Robert Fisk
Neanderthals lived alongside humans for centuries, latest study shows

Final resting place of our Neanderthal neighbours revealed

Bones dated to 40,000 years ago show species may have died out in Belgium species co-existed
Scottish independence: The new Scots who hold fate of the UK in their hands

The new Scots who hold fate of the UK in their hands

Scotland’s immigrants are as passionate about the future of their adopted nation as anyone else
Britain's ugliest buildings: Which monstrosities should be nominated for the Dead Prize?

Blight club: Britain's ugliest buildings

Following the architect Cameron Sinclair's introduction of the Dead Prize, an award for ugly buildings, John Rentoul reflects on some of the biggest blots on the UK landscape
eBay's enduring appeal: Online auction site is still the UK's most popular e-commerce retailer

eBay's enduring appeal

The online auction site is still the UK's most popular e-commerce site
Culture Minister Ed Vaizey: ‘lack of ethnic minority and black faces on TV is weird’

'Lack of ethnic minority and black faces on TV is weird'

Culture Minister Ed Vaizey calls for immediate action to address the problem
Artist Olafur Eliasson's latest large-scale works are inspired by the paintings of JMW Turner

Magic circles: Artist Olafur Eliasson

Eliasson's works will go alongside a new exhibition of JMW Turner at Tate Britain. He tells Jay Merrick why the paintings of his hero are ripe for reinvention
Josephine Dickinson: 'A cochlear implant helped me to discover a new world of sound'

Josephine Dickinson: 'How I discovered a new world of sound'

After going deaf as a child, musician and poet Josephine Dickinson made do with a hearing aid for five decades. Then she had a cochlear implant - and everything changed
Greggs Google fail: Was the bakery's response to its logo mishap a stroke of marketing genius?

Greggs gives lesson in crisis management

After a mishap with their logo, high street staple Greggs went viral this week. But, as Simon Usborne discovers, their social media response was anything but half baked
Matthew McConaughey has been singing the praises of bumbags (shame he doesn't know how to wear one)

Matthew McConaughey sings the praises of bumbags

Shame he doesn't know how to wear one. Harriet Walker explains the dos and don'ts of fanny packs
7 best quadcopters and drones

Flying fun: 7 best quadcopters and drones

From state of the art devices with stabilised cameras to mini gadgets that can soar around the home, we take some flying objects for a spin
Joey Barton: ‘I’ve been guilty of getting a bit irate’

Joey Barton: ‘I’ve been guilty of getting a bit irate’

The midfielder returned to the Premier League after two years last weekend. The controversial character had much to discuss after his first game back
Andy Murray: I quit while I’m ahead too often

Andy Murray: I quit while I’m ahead too often

British No 1 knows his consistency as well as his fitness needs working on as he prepares for the US Open after a ‘very, very up and down’ year
Ferguson: In the heartlands of America, a descent into madness

A descent into madness in America's heartlands

David Usborne arrived in Ferguson, Missouri to be greeted by a scene more redolent of Gaza and Afghanistan
BBC’s filming of raid at Sir Cliff’s home ‘may be result of corruption’

BBC faces corruption allegation over its Sir Cliff police raid coverage

Reporter’s relationship with police under scrutiny as DG is summoned by MPs to explain extensive live broadcast of swoop on singer’s home